Specific activation of resting T cells against CA19-9+ tumor cells by an anti-CD3/CA19-9 bispecific antibody in combination with a costimulatory anti-CD28 antibody.

Source:http://linkedlifedata.com/resource/pubmed/id/9336739

Download in:

View as

General Info

PMID
9336739